Amanda Pierz

Doctoral Fellow, Adjunct Faculty Specialization in Maternal, Reproductive, and Sexual Health

Amanda is a social epidemiologist and global health researcher specializing in qualitative and mixed methodologies. Her research experience has primarily centered on HIV and HPV co-infections in Central Africa and the Bronx in longitudinal and cohort studies, including the Central Africa International epidemiology Databases to Evaluate AIDS (CA-IeDEA), the Einstein/Rwanda/DRC Consortium for Research in HIV/HPV/Malignancies, and the MACS/WIHS Combined Cohort Study. 

Currently, she serves as an Adjunct Faculty member at both CUNY School of Public Health in the Departments of Community Health & Social Sciences and Health Policy & Management, and York College in the Department of Health and Human Performance. Other recent work includes the mixed-methods assessment of patient, staff and provider perspectives on a comprehensive, integrated geriatric-HIV program at the Center for Positive Living (CPL) at Montefiore Medical Center and providing technical support to the WHO Interdepartmental Task Force to develop guidance for low- and middle-income countries (LMICs) on safety surveillance in pregnancy.

CIRGH Focus Areas

Data Systems Strengthening: Maternal and newborn safety surveillance in low- and middle-income countries

Access to Care

Key Organizational Relationships

Research Associate, Integrated Geriatric HIV Care Demonstration Project at Montefiore Medical Center


MSc in Global Health, Maastricht University, Maastricht, Netherlands

BS in Public Health, Rutgers, The State University of New Jersey, New Brunswick, NJ


Select Publications

  • Pierz AJ & Dapi LN. Traditional and colonial governance practices and their impact on women’s identities and experiences in French Cameroon: a retrospective study. Social Identities 2021. doi: 10.1080/13504630.2021.1997734.
  • Adedimeji AA, Ajeh R, Pierz A, Nkeng R, Ndenkeh J, Fuhngwa N, Nsame D, Nji M, Dzudie A, Anastos KM, Castle PE. Challenges and opportunities to reduce the burden of cervical cancer in a low income, high HIV prevalence context. BMC Women’s Health 2021. doi: 10.21203/rs.2.20620/v2
  • Pierz AJ, Ajeh R, Fuhngwa N, Nasah J, Dzudie A, Nkeng R, Anastos KM, Castle PE, Adedimeji A. Acceptability of Self-Sampling for Cervical Cancer Screening Among Women Living With HIV and HIV-Negative Women in Limbé, Cameroon. Front Repro Health 2021;2. doi: 10.3389/frph.2020.561202
  • Castle P, Pierz A, Adcock R, Aslam S, Basu P, Belinson J, Cuzick J, El-Zein M, Ferreccio C, Firnhaber C, Franco  E, Gravitt P, Isidean S, Li J, Mahmud S, Monsonego J, Muwonge R, Ratnam S, Safaeian M, Xi, L. A pooled analysis to compare the clinical characteristics of human papillomavirus-positive and -negative cervical precancers. Cancer Prevention Research 2020;0182.2020. doi: 10.1158/1940-6207.CAPR-20-0182
  • Pierz AJ, Randall TC, Castle PE, Adedimeji A, Ingabire C, Kubwimana G, Uwinkindi F, Hagenimana M, Businge L, Musabyimana F, Munyaneza A, Murenzi G. A scoping review: Facilitators and barriers of cervical cancer screening and early diagnosis of breast cancer in Sub-Saharan African health settings. Gyn Onc Reports 2020;33:100605. doi: 10.1016/j.gore.2020.100605
  • Castle P & Pierz A. (At Least) Once in a Lifetime: Global Cervical Cancer Prevention. Obstetrics and Gynecology Clinics of North America 2019;46(1):107-123. doi: 10.1016/j.ogc.2018.09.007.
  • Castle PE, Pierz AJ, Stoler MH. A systematic review and meta-analysis on the attribution of human papillomavirus (HPV) in neuroendocrine cancers of the cervix. Gynecological Oncology 2018;148(2):422-429. doi: 10.1016/j.ygyno.2017.12.001.